Ubiquitination of HIV-1 and MuLV Gag

Virology

Volumn 278, Issue 1, 2000, Pages 111-121

  Ott, David E ^a   Coren, Lori V ^a   Chertova, Elena N ^a   Gagliardi, Tracy D ^a   Schubert, Ulrich ^b,c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

GAG PROTEIN;

ARTICLE; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; PRIORITY JOURNAL; VIRION; VIRUS ASSEMBLY; VIRUS ISOLATION; VIRUS REPLICATION;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0034610238     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.2000.0648     Document Type: Article

References (48)

1. Productive, persistent infection of human colorectal cell lines with human immunodeficiency virus
2. Rapid cell culture assay technique for murine leukaemia viruses
3. Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations
4. A multiubiquitin chain is confined to specific lysine in a targeted short-lived protein
5. The ubiquitin-proteasome pathway: On protein death and cell life
6. Deubiquitinating enzymes: A new class of biological regulators
7. Proline residues in human immunodeficiency virus type 1 p6(Gag) exert a cell type-dependent effect on viral replication and virion incorporation of Pol proteins
8. Ubiquitination
9. WW domains and retrovirus budding
10. Cell membrane vesicles are a major contaminant of gradientenriched human immunodeficiency virus type-1 preparations
11. Genetic analysis of the zinc finger in the Moloney murine leukemia virus nucleocapsid: Replacement of zinc-binding residues with other zinc-binding residues yields noninfectious particles containing genomic RNA
12. Point mutants of Moloney murine leukemia virus that fail to package viral RNA: Evidence for specific RNA recognition by a 'zinc finger-like' protein sequence
13. Noninfectious human immunodeficiency virus type 1 mutants deficient in genomic RNA
14. Effect of mutations affecting the p6 gag protein on human immunedeficiency virus particle release
15. Identification of a novel ubiquitin conjugation motif, required for ligand-induced internalization of the growth hormone receptor
16. Chemical and immunological characterizations of equine infectious anemia virus gag-encoded proteins
17. The ubiquitin system
18. Gettin' down with ubiquitin: Turning off cell-surface receptors, transporters and channels
19. Ubiquitin-dependent protein degradation
20. Gene splicing by overlap extension: Tailor-made genes using polymerase chain reaction
21. Activation-dependent ubiquitination of a T celt antigen receptor subunit on multiple intracellular lysines
22. p6gag is required for particle production from full-length human immuno-deficiency virus type 1 molecular clones expressing protease
23. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated beta-galactosidase gene
24. Intracellular transport of retroviral capsid components
25. Substrate targeting in the ubiquitin system
26. Proteasome inhibiters: Valuable new tools for cell biologists
27. Mutational analysis of the hydrophobic tail of the human immunodeficiency virus type 1 p6(Gag) protein produces a mutant that fails to package its envelope protein
28. Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type-1 and simian immunodeficiency virus and the p12Gag protein of Moloney murine leukemia virus
29. Actin-binding cellular proteins inside human immunodeficiency virus type 1
30. Analysis and localization of cyclophilin A found in the virions of human immunodeficiency virus type 1 MN strain
31. Cytoskeletal proteins inside human immunodeficiency virus type 1 virions
32. Positionally independent and exchangeable late budding functions of the Rous sarcoma virus and human immunodeficiency virus Gag proteins
33. Equine infectious anemia virus utilizes a YXXL motif within the late assembly domain of the Gag p9 protein
34. Equine infectious anemia virus gag polyprotein late domain specifically recruits cellular AP-2 adapter protein complexes during virion assembly
35. Ubiquitin in avian leukosis virus particles
36. The ubiquitin-conjugation system
37. CD4 glycoprotein degradation induced by human immunodeficiency virus type 1 Vpu protein requires the function of proteasomes and the ubiquitinconjugating pathway
38. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes
39. Proteasome inhibition interferes with Gag polyprotein processing, release, and maturation of human immunodeficiency viruses
40. Antiviral activity of the proteasome on incoming human immunodeficiency virus type 1
41. Monoubiquitin carries a novel internalization signal that is appended to activated receptors
42. Synthesis, assembly, and processing of viral proteins
43. Recognition of the polyubiquitin proteolytic signal
44. Ubiquitin-dependent c-Jun degradation in vivo is mediated by the delta domain
45. Retroviral virions and genomes
46. Infectivity of Moloney murine leukemia virus defective in late assembly
47. Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle